Pharsight

Drug patents revoked in 2021

Drug patents revoked in 2021 at the European Patent Office (EPO).

Patent Number Patent Title Company Revoked Date Oppositions
EP2527457B1 Widespread gene delivery to motor neurons using peripheral injection of aav vectors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS Dec, 2021
(Expiration: Oct, 2028)
BEZZUBOVA
EP3377110B1 Nanoparticles based on optionally alkoxylated poly(alkyl cyanoacrylates) having a defined degree of polymerization ABBVIE DEUTSCHLAND GMBH AND CO KG Dec, 2021
(Expiration: Oct, 2036)
SINTEF TTO
EP3002298B1 Anti-factor xi monoclonal antibodies and methods of use thereof OREGON HEALTH SCIENCE UNIVERSITY Dec, 2021
(Expiration: Nov, 2028)
MERCK SHARP & DOHME
EP3104844B1 Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them DRUGGABILITY TECHNOLOGIES IP HOLDCO LTD Dec, 2021
(Expiration: Feb, 2035)
ALKERMES PHARMA IRELAND
EP3226829B1 A personal care cream composition UNILEVER PLC Dec, 2021
(Expiration: Nov, 2035)
THE PROCTER & GAMBLE
EP1797886B1 Immunostimulation by chemically modified RNA CUREVAC AG Dec, 2021
(Expiration: Jul, 2023)
KNIG SZYNKA TILMANN VON RENESSE
WEINZIERL
EP2872533B1 Methods of assessing the suitability of transduced t cells for administration UNIVERSITY OF PENNSYLVANIA PENN Dec, 2021
(Expiration: Jul, 2033)
PATENT BOUTIQUE
ZWICKER SCHNAPPAUF & PARTNER PATENTANWLTE PARTG MBB
EP2133365B1 Compositions and methods for the treatment of infections and tumors HARVARD COLLEGE Dec, 2021
(Expiration: Dec, 2027)
PFIZER
EP2598151B1 Compositions for treating heartworm infestation CEVA SANTE ANIMALE SA Dec, 2021
(Expiration: Jul, 2031)
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2934455B1 Combination of active agents comprising at least one essential oil, one cyclodextrin and one liquid fatty substance and composition comprising it LOREAL SA Dec, 2021
(Expiration: Dec, 2033)
THE PROCTER & GAMBLE
EP2380581B1 Muscle-building agent MEGMILK SNOW BRAND CO LTD Nov, 2021
(Expiration: Dec, 2029)
ARLA FOODS AMBA
FRESENIUS KABI DEUTSCHLAND
NUTRICIA
EP3045471B1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation FERRING BV Nov, 2021
(Expiration: Apr, 2029)
MERCK SERONO
EP2680881B1 Vaccination in elderly patients CUREVAC AG Nov, 2021
(Expiration: Feb, 2032)
STRAWMAN
EP1925282B1 Low density cosmetic formulations, cosmetic products containing the same and methods of cosmetic treatment of hair, and/or skin using the same LOREAL SA Nov, 2021
(Expiration: Nov, 2027)
HENKEL
EP3395338B1 Rapid dissolution formulation of cinacalcet hcl AMGEN INC Nov, 2021
(Expiration: Sep, 2024)
ACCORD HEALTHCARE
AECHTER
BETAPHARM ARZNEIMITTEL
BIOGARAN
GLENMARK PHARMACEUTICALS EUROPE
HGF
TEVA PHARMACEUTICAL INDUSTRIES
EP2460820B8 Pcv2 immunogenic compositions and methods of producing such compositions BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC Nov, 2021
(Expiration: Dec, 2025)
CEVA SANTE ANIMALE
ELANCO
LABORATORIOS HIPRA
EP2622971B1 Method for controlling the digestive coagulation of proteins NUTRICIA NV Nov, 2021
(Expiration: Apr, 2030)
ABBOTT LABORATORIES
FRESENIUS KABI DEUTSCHLAND
NESTEC
EP2724728B1 Complexes of il-15 and il-15r alpha and uses thereof NOVARTIS AG Nov, 2021
(Expiration: Jun, 2028)
HGF
EP2344141B1 Compositions comrrising amlodipine and bisoprolol EGYT GYOGYSZERVEGYESZETI GYAR Nov, 2021
(Expiration: Sep, 2029)
KRKA
EP3143985B1 Use of probiotic microorganisms to reduce skin irritation SOCIETE DES PRODUITS NESTLE SA Nov, 2021
(Expiration: Mar, 2030)
CHR HANSEN
LACBIOME
SOFAR
EP2324834B1 Methods of Increasing Endogenous Erythropoietin (EPO) FIBROGEN INC Nov, 2021
(Expiration: Dec, 2022)
AKEBIA THERAPEUTICS
EP2056845B1 Structure and use of 5' phosphate oligonucleotides RHEINISCHE FRIEDRICH WILHELMS UNIVERSITAET BONN Nov, 2021
(Expiration: Aug, 2027)
WITHERS & ROGERS
EP2278002B1 Pancreatin with reduced viral content ABBOTT LABORATORIES GMBH Oct, 2021
(Expiration: Jul, 2026)
NORDMARK ARZNEIMITTEL
EP2519300B1 System for treating target tissue within the eustachian tube ACCLARENT INC Oct, 2021
(Expiration: Dec, 2030)
SPIGGLE & THEIS MEDIZINTECHNIK
EP2760425B8 Foam oxidative hair colorant composition with the free-base of 1, 4-diamino-2-methoxymethyl benzene NOXELL CORP Oct, 2021
(Expiration: Sep, 2032)
HENKEL
EP2803366B1 Compositions for treating or preventing oxalate-related disease OXTHERA INTELLECTUAL PROPERTY AB Oct, 2021
(Expiration: Jun, 2025)
POHLMAN
EP2223688B1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof CELGENE CORP Oct, 2021
(Expiration: Mar, 2023)
GALENICUM HEALTH SLU
HEXAL
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
ZENTIVA KS
EP3072499B1 Octocrylene-free sunscreen with low adhesion BEIERSDORF AG Oct, 2021
(Expiration: Jan, 2035)
DALLI WERKE
DSM NUTRITIONAL PRODUCTS
LOREAL
EP1991267B1 Methods of treating inflammatory and autoimmune diseases with natalizumab BIOGEN MA INC Oct, 2021
(Expiration: Mar, 2027)
PHARMACEUTICAL WORKS POLPHARMA
EP3272397B1 Agent for oxidative hair dye and method for stabilizing color tone of oxidative hair dye composition HOYU CO LTD Oct, 2021
(Expiration: Jul, 2037)
HENKEL
LOREAL
EP2859075B1 Biosolubilizer GIVAUDAN SA Oct, 2021
(Expiration: May, 2033)
CRODA
EVONIK OPERATIONS
EP3054993B1 Permanent gene correction by means of nucleotide-modified messenger rna HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG FUR DAS HELMHOLTZ INST FUR PHARMAZEUTISCHE FORSCHU GMBH Oct, 2021
(Expiration: Oct, 2034)
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
EP3210592B1 Silica and dentifrice composition comprising the same EVONIK DEGUSSA GMBH Oct, 2021
(Expiration: Feb, 2031)
PQ PQ SILICAS UK
EP2925299B1 Novel pharmaceutical composition NOVARTIS AG Oct, 2021
(Expiration: Nov, 2033)
GENERICS UK
EP2842569B1 One dose vaccination with Mycoplasma hyopneumoniae ZOETIS SERVICES LLC Oct, 2021
(Expiration: Jun, 2022)
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2648520B1 Dexmedetomidine premix formulation HOSPIRA INC Oct, 2021
(Expiration: Jun, 2032)
FRESENIUS KABI DEUTSCHLAND
EP2658546B1 Methods of using human milk oligosaccharides for improving airway respiratory health ABBOTT LABORATORIES Oct, 2021
(Expiration: Dec, 2031)
SOCIT DES PRODUITS NESTL
EP2688561B1 Transdermal compositions comprising an active agent layer and an active agent conversion layer TEIKOKU PHARMA USA INC Oct, 2021
(Expiration: Mar, 2032)
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP2814450B1 Stable water-in-oil emulsions with hlb-type emulsifiers BEIERSDORF AG Sep, 2021
(Expiration: Feb, 2033)
EVONIK OPERATIONS
EP3160428B1 A sebum-promoting agent for improving hair UNILEVER PLC Sep, 2021
(Expiration: Jun, 2035)
THE PROCTER & GAMBLE
EP2425821B1 Pharmaceutical preparation containing oxycodone and naloxone EURO CELTIQUE SA Sep, 2021
(Expiration: Apr, 2023)
ACINO PHARMA
DEVELCO PHARMA SCHWEIZ
ETHYPHARM
GLENMARK PHARMACEUTICALS EUROPE
G L PHARMA
HEXAL SANDOZ
INTAS PHARMACEUTICALS
KRKA
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA
EP3461895B1 Modulation of ube3a-ats expression BAYLOR COLLEGE OF MEDICINE Sep, 2021
(Expiration: Jun, 2033)
F HOFFMANN LA ROCHE
EP2190434B1 Purin derivatives for use in the treatment of fap-related diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH Sep, 2021
(Expiration: Aug, 2028)
HEXAL
EP2768479B1 Excipients for nicotine-containing therapeutic compositions MODORAL BRANDS INC Sep, 2021
(Expiration: Oct, 2032)
PHILIP MORRIS PRODUCTS
EP1622470B1 Alginate matrix particles GIVAUDAN SA Sep, 2021
(Expiration: May, 2024)
OMYA
EP3233030B1 Composition in the form of o/w emulsion LOREAL SA Sep, 2021
(Expiration: Dec, 2035)
HENKEL
KAO GERMANY
EP2837407B1 Octocrylene-free, odour-stable sun protection agent BEIERSDORF AG Aug, 2021
(Expiration: Jun, 2034)
BASF
DSM NUTRITIONAL PRODUCTS
LOREAL
EP2997134B1 Human application of engineered chimeric antigen receptor (car) t-cells UNIVERSITY OF TEXAS SYSTEM Aug, 2021
(Expiration: May, 2034)
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP3395331B1 Pharmaceutical tablet composition comprising eltrombopag olamine ALFRED E TIEFENBACHER GMBH AND CO KG Aug, 2021
(Expiration: Jul, 2037)
BLLE DR
EP2056832B1 Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate ASTRAZENECA AB Aug, 2021
(Expiration: Aug, 2027)
GENERICS UK TRADING MYLAN
HEXAL BIOTECH
WITTKOPP
EP2674408B1 Translucent zirconia sintered body and use of the same TOSOH CORP Aug, 2021
(Expiration: Apr, 2029)
HOFFMANN EITLE
M DEUTSCHLAND DE M INNOVATIVE PROPERTIES
TREIBACHER INDUSTRIE
EP2788019B1 Exosomes for delivery of biotherapeutics OXFORD UNIVERSITY INNOVATION LTD Aug, 2021
(Expiration: Dec, 2032)
TRUSCOTT
EP3070090B1 Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile INCYTE HOLDINGS CORP Aug, 2021
(Expiration: Jun, 2028)
GENERICS UK
EP3087098B1 Anti-vista antibodies and fragments JANSSEN PHARMACEUTICA NV Aug, 2021
(Expiration: Dec, 2034)
MARGARET DIXON
REGIMBEAU
EP2646003B1 Rapidly dispersing granules, orally disintegrating tablets and methods ADARE PHARMACEUTICALS INC Aug, 2021
(Expiration: Dec, 2031)
DR FALK PHARMA
EP2448551B1 Ester mixtures and compositions comprising such ester mixtures COGNIS IP MANAGEMENT GMBH Aug, 2021
(Expiration: Jun, 2030)
KADOR & PARTNER PARTG MBB
EP2854790B1 Use of n-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media ARES TRADING SA Aug, 2021
(Expiration: May, 2033)
FERRING
EP2305711B1 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same RINAT NEUROSCIENCE CORP Jul, 2021
(Expiration: Apr, 2026)
REGENERON PHARMACEUTICALS
EP1845956B1 Break-resistant delayed-release forms of administration GRUENENTHAL GMBH Jul, 2021
(Expiration: Feb, 2026)
G L PHARMA
EP3024461B1 A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation EURO CELTIQUE SA Jul, 2021
(Expiration: Jul, 2034)
DEVELCO PHARMA SCHWEIZ
HEXAL PHARMA
EP2836196B1 Preparation for topical application to mucosa containing polyhexanide as active ingredient MERZ PHARMA GMBH AND CO KGAA Jul, 2021
(Expiration: Apr, 2033)
MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT
EP2962686B1 Dosage form containing oxycodone and naloxone EURO CELTIQUE SA Jul, 2021
(Expiration: Feb, 2026)
ARISTO PHARMA
DEVELCO PHARMA SCHWEIZ
ETHYPHARM
HEXAL SANDOZ
KRKA
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
EP2797570B1 Use for reduced staining and improved washability BEIERSDORF AG Jul, 2021
(Expiration: Dec, 2032)
THE PROCTER & GAMBLE
EP2970677B1 Small scale microencapsulated pigments and uses thereof CHROMATIC TECHNOLOGIES INC Jul, 2021
(Expiration: Mar, 2034)
SOCIT BIC
EP2863876B1 Hair colorant compositions comprising 2-methoxymethyl-1,4-diaminobenzene, methods, and kits NOXELL CORP Jul, 2021
(Expiration: Jun, 2033)
HENKEL
EP3179989B1 Silicone-containing acrylic polymers for transdermal drug delivery compositions NOVEN PHARMACEUTICALS INC Jul, 2021
(Expiration: Jul, 2035)
LTS LOHMANN THERAPIE SYSTEME
EP2494983B1 Stable formulations of glp-1 NOVO NORDISK AS Jul, 2021
(Expiration: Nov, 2025)
HGF
HOFFMANN EITLE
EP2214679B1 Corticosteroid compositions MERITAGE PHARMA INC Jun, 2021
(Expiration: Nov, 2028)
AECHTER
DR FALK PHARMA
EP2861234B1 Progesterone formulations THERAPEUTICSMD INC Jun, 2021
(Expiration: Jun, 2033)
RIECK
EP2945628B1 Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer ARAGON PHARMACEUTICALS INC Jun, 2021
(Expiration: Jan, 2034)
GENERICS UK
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
SYNTHON
TEVA PHARMACEUTICAL INDUSTRIES
EP3222266B1 Compositions and methods for targeted thermomodulation SIENNA BIOPHARMACEUTICALS INC Jun, 2021
(Expiration: Aug, 2031)
SEBACIA
EP1317918B1 Cosmetic sunscreen compositions based on synergistic filter mixture and their use LOREAL SA Jun, 2021
(Expiration: Nov, 2022)
STADA ARZNEIMITTEL
EP2289352B1 Agent for use in the case of fructose intolerance VITACARE GMBH AND CO KG Jun, 2021
(Expiration: Feb, 2028)
STADA ARZNEIMITTEL
EP3060303B1 Mrna therapy for argininosuccinate synthetase deficiency TRANSLATE BIO INC Jun, 2021
(Expiration: Oct, 2034)
WITHERS & ROGERS
EP3027174B1 Pharmaceutical compositions of fingolimod AIZANT DRUG RES SOLUTIONS PRIVATE LTD Jun, 2021
(Expiration: Dec, 2033)
DF MP DRRIES FRANK MOLNIA & POHLMAN
EP3065731B1 Methods and compositions for improving kidney function HILLS PET NUTRITION INC Jun, 2021
(Expiration: Nov, 2033)
IAMS EUROPE
EP3307393B1 Fragrance composition PROCTER AND GAMBLE CO May, 2021
(Expiration: Jun, 2036)
HENKEL
EP2797581B1 Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione AMGEN EUROPE GMBH May, 2021
(Expiration: Dec, 2032)
GALENICUM HEALTH SLU
GENERICS UK
KRKA
EP3236938B1 Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol SANOVEL ILAC SANAYI VE TICARET AS May, 2021
(Expiration: Dec, 2035)
RECKITT BENCKISER HEALTH
EP3127427B1 Methods of administration of thrombopoietin agonist compounds NOVARTIS AG May, 2021
(Expiration: May, 2030)
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA KS
EP2711024B1 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same UNITED THERAPEUTICS CORP May, 2021
(Expiration: Sep, 2028)
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
EP2794014B1 Product for temporarily shaping keratin fibers on the basis of a combination of specific film-forming polymers HENKEL AG AND CO KGAA May, 2021
(Expiration: Nov, 2032)
LOREAL
EP2773338B1 Improving recognition NUTRICIA NV May, 2021
(Expiration: Oct, 2032)
SOCIT DES PRODUITS NESTL
EP1617823B1 A pouch comprising a nicotine composition for transmucosal delivery NICACHET AB May, 2021
(Expiration: Jan, 2024)
KELTIE
EP2649982B1 Hair bleaching composition and method for producing same ARTEC CHEMICAL CO LTD May, 2021
(Expiration: Mar, 2033)
KAO GERMANY
LOREAL
EP3075744B1 Improved recombinant human follicle-stimulating hormone GLYCOTOPE GMBH May, 2021
(Expiration: Aug, 2031)
AUGUST DEBOUZY
EP3209387B1 Use of chitosans in antiperspirant compositions free of halogen or halogenhydroxysalts of aluminum and or zirconium HENKEL AG AND CO KGAA Apr, 2021
(Expiration: Sep, 2035)
THE PROCTER & GAMBLE
EP3093009B1 Octocrylene-free sunscreen agent with diethylaminohydroxybenzoylhexylbenzoate BEIERSDORF AG Apr, 2021
(Expiration: May, 2036)
DALLI WERKE
EMIL KIESSLING
LOREAL
MIBELLE
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
EP3116527B1 Method for preparing human plasma proteins LFB SA Apr, 2021
(Expiration: Mar, 2035)
CSL BEHRING
EP3058958B1 Anidulafungin composition SELECTCHEMIE AG Apr, 2021
(Expiration: Feb, 2036)
COOKE
EP3027063B1 Opo glyceride composition BUNGE LODERS CROKLAAN BV Apr, 2021
(Expiration: Jul, 2034)
FRUTAROM
NEDERLANDSCH OCTROOIBUREAU
EP3000805B1 C7-fluoro substituted tetracycline compounds TETRAPHASE PHARMACEUTICALS INC Apr, 2021
(Expiration: Aug, 2029)
SANDOZ
EP1846030B1 Fixed dosing of her antibodies GENENTECH INC Apr, 2021
(Expiration: Jun, 2025)
BREUER
DR H ULRICH DRRIES
KNIG SZYNKA TILMANN VON RENESSE
LEEMING
EP3030666B1 Compositions and methods for treatment of muscular dystrophy CONSIGLIO NAZIONALE DELLE RICHERCHE CNR Apr, 2021
(Expiration: Jul, 2034)
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP2337849B1 Factor ix polypeptide mutant, its uses and a method for its production UNIQURE BIOPHARMA BV Mar, 2021
(Expiration: Sep, 2029)
BAXALTA
GREAVES BREWSTER
PFIZER
STRAWMAN
WEINZIERL
EP2680885B8 Combination vaccines with lower doses of antigen and/or adjuvant GLAXOSMITHKLINE BIOLOGICALS SA Mar, 2021
(Expiration: Mar, 2032)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
EP2822383B1 Antimicrobial compostion containing lauric acid and method for their production CARGILL INC Mar, 2021
(Expiration: Mar, 2033)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
NUTRITION SCIENCES
EP3033079B1 Methods for the treatment of her2 amplified cancer PHARMACYCLICS LLC Mar, 2021
(Expiration: Aug, 2034)
GENERICS UK
EP2658509B1 Hair colouring composition comprising gluconic acid and/or its salts KAO GERMANY GMBH Mar, 2021
(Expiration: Dec, 2031)
HENKEL
EP3112377B1 Bifunctional polypeptides IMMUNOCORE LTD Mar, 2021
(Expiration: May, 2030)
MICHALSKI HTTERMANN & PARTNER PATENTANWLTE MBB
EP3248600B8 Combinations and modes of administration of therapeutic agents and combination therapy ABRAXIS BIOSCIENCE LLC Mar, 2021
(Expiration: Feb, 2026)
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
EP1784222B1 Nutritional composition comprising indigestible oligosaccharides NUTRICIA NV Mar, 2021
(Expiration: Aug, 2025)
SOCIT DES PRODUITS NESTL
EP2374472B9 Compositions and methods for treating ophthalmic disorders DYAX CORP Mar, 2021
(Expiration: Mar, 2027)
BICYCLETX
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
OXURION
EP2822591B1 Pharmaceutical formulations of tnf-alpha antibodies CADILA HEALTHCARE LTD Mar, 2021
(Expiration: Mar, 2033)
BOULT WADE TENNANT
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
EP2670429B1 Method for inactivation/removal of coagulation factors by precipitation OCTAPHARMA AG Mar, 2021
(Expiration: Feb, 2032)
BIOTEST
STRAWMAN
EP3261485B1 Cosmetic product having a metal can, and the contents of same BEIERSDORF AG Mar, 2021
(Expiration: Feb, 2036)
HENKEL
EP2773334B1 Composition with sustained antimicrobial activity COLUMBIA UNIVERSITY OF NEW YORK Feb, 2021
(Expiration: Nov, 2032)
HENKEL
EP2346355B1 Nutritional compositions with large diameter lipid globules with a coating comprising polar lipids NUTRICIA NV Feb, 2021
(Expiration: Sep, 2029)
FRESENIUS KABI DEUTSCHLAND
EP3093005B1 Octocrylene-free sunscreen comprising diethyl hexyl butamido triazone BEIERSDORF AG Feb, 2021
(Expiration: May, 2036)
DALLI WERKE
DSM NUTRITIONAL PRODUCTS
EMIL KIESSLING
LOREAL
MIBELLE
PLOUGMANN VINGTOFT
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
EP3195853B1 Octocrylene-free solar protection formulation with diethylamino hydroxybenzoyl hexyl benzoate. BEIERSDORF AG Feb, 2021
(Expiration: Jan, 2037)
EMIL KIESSLING
EP2486141B1 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use MACROGENICS INC Feb, 2021
(Expiration: Oct, 2030)
ISENBRUCK BSL HRSCHLER
STRAWMAN
EP2968221B1 Pharmaceutical composition of s-ketamine hydrochloride JANSSEN PHARMACEUTICA NV Jan, 2021
(Expiration: Mar, 2034)
ASPIRE PHARMA
SANDOZ
EP2850189B8 Compositions and methods for modulating gene expression GENERAL HOSPITAL CORP Jan, 2021
(Expiration: May, 2033)
ROCHE INNOVATION CENTER COPENHAGEN
EP2345425B1 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs LFB SA Jan, 2021
(Expiration: Dec, 2026)
OCTAPHARMA
TAKEDA PHARMACEUTICALS
EP3167900B1 Vaccine against streptococci MERIAL LTD Jan, 2021
(Expiration: Mar, 2027)
AWA SWEDEN
EP3112376B1 Bifunctional polypeptides IMMUNOCORE LTD Jan, 2021
(Expiration: May, 2030)
STORZ